🇺🇸 Tetanus/diphtheria toxoids in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 6
Most-reported reactions
- Cardiac Disorder — 1 report (16.67%)
- Off Label Use — 1 report (16.67%)
- Pneumonia — 1 report (16.67%)
- Skin Discolouration — 1 report (16.67%)
- Syncope — 1 report (16.67%)
- Tick Removal — 1 report (16.67%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is Tetanus/diphtheria toxoids approved in United States?
Tetanus/diphtheria toxoids does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Tetanus/diphtheria toxoids in United States?
London School of Hygiene and Tropical Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.